Non-invasive pulse wave recording and analysis system for cardiovascular disease risk assessment. Generates clinical measurements including central systolic blood pressure, pulse wave velocity, and heart-brain relative risk scores through advanced tonometry sensors and AI algorithms.
Manufactured by
South Korea
Harvey Cardio Co., Ltd. – Innovating Cardiovascular Disease Screening Through Precision Technology Havey Cardio is setting a new standard in cardiovascular and cerebrovascular screening through our proprietary Pulse Wave Transit Time Ratio (PWR) analysis technology. 1. Technological Innovation: Unmatched Precision - Traditional Pulse Wave Velocity (PWV) methods often suffer from measurement errors depending on the patient’s body type or the practitioner’s technique. We have overcome these limitations by developing a technology that analyzes pulse wave data based on time ratios alone, eliminating the need for distance measurements. This breakthrough has been clinically validated, achieving a high diagnostic accuracy of approximately 82% in sensitivity and specificity. 2. Practical Innovation: Accessibility and Ease of Use - Equipped with our self-developed, high-sensitivity digital pressure sensors, our solution enables the simultaneous, accurate, and convenient measurement of pulse waves from multiple body points. We provide an environment where cardiovascular health can be managed easily not only in specialized general hospitals but also in primary care clinics, making preventive screening more accessible than ever. 3. Future Innovation: Synergy Between AI and Expertise - Our robust R&D ecosystem is led by executives with extensive experience in the pharmaceutical and healthcare industries, alongside a dedicated team of Ph.D. researchers in biomedical engineering. We are currently advancing a next-generation diagnostic platform that utilizes Artificial Intelligence (AI) simulations to detect subtle anomalies in pulse wave signals. Our Vision: Following our certification as a Venture Business and the official recognition of our Corporate R&D Center in 2025, Harvey Cardio is now poised for a major leap forward. Our mission is clear: to contribute to global health by developing innovative methods for the early detection and prevention of cardiovascular diseases, ensuring a healthier life for all humanity.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
CNSystems Medizintechnik GmbH
Austria · 2 relevant products
ATCOR MEDICAL PTY LTD
China · 3 relevant products
Aireen a.s.
Czech Republic · 2 relevant products
Beijing Laxons Technology Co., Ltd.
China · 3 relevant products
DAEYOMEDI Co., Ltd.
South Korea · 4 relevant products
FaceHeart Inc.
Taiwan · 3 relevant products
Cardiex Limited
China · 2 relevant products
Optain Health
Australia · 1 relevant product
CLD
China · 2 relevant products
BEI JING CHIOY MEDICAL TECHNOLOGY CO.,LTD
China · 1 relevant product
16 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →1 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 39 closest product alternatives
CNSystems Medizintechnik GmbH · Austria
Comprehensive non-invasive cardiovascular evaluation system combining continuous hemodynamic monitoring with ECG assessment. Supports diagnostic decision making for cardiovascular pathologies including syncope and hypotension.
ATCOR MEDICAL PTY LTD · China
Comprehensive system for evaluating cardiac function without invasive procedures. Delivers detailed cardiovascular parameters for patient monitoring and risk assessment.
Aireen a.s. · Czech Republic
Diagnostic system analyzing retinal biomarkers and vascular damage from fundus photographs to assess risk of cardiovascular events. Evaluates stroke and ischemic heart disease risk through automated retinal image analysis in patients with vascular disease. Supports preventive cardiology and risk stratification.
Aireen a.s. · Czech Republic
Automated analysis platform for evaluating vascular and retinal damage in hypertensive patients using fundus photography. Classifies hypertensive eye damage into four clinical grades, supporting assessment by ophthalmologists, cardiologists, and internists. Assists in comprehensive hypertensive patient evaluation.
Beijing Laxons Technology Co., Ltd. · China
An integrated system for comprehensive hemodynamic evaluation combining vascular ultrasound and photoplethysmographic measurements. The platform supports multi-parameter assessment of peripheral vascular function.
CNSystems Medizintechnik GmbH · Austria
Complete diagnostic system for syncope evaluation combining non-invasive continuous hemodynamic measurement with ECG monitoring according to clinical guidelines. Supports rapid detection of cardiovascular changes during syncope assessment procedures.
DAEYOMEDI Co., Ltd. · South Korea
Diagnostic device that captures and analyzes three-dimensional pulse imagery using advanced sensor technology. Provides comprehensive cardiovascular assessment through non-invasive pulse wave analysis and visualization of vascular characteristics.
FaceHeart Inc. · Taiwan
Non-invasive blood pressure measurement device utilizing facial video analysis and AI algorithms. Enables rapid assessment without traditional cuff-based measurement.
Cardiex Limited · China
Complete system designed for rapid arterial health assessment at the point of care, enabling identification of cardiovascular risk. Provides clinically relevant vascular health data to inform treatment decisions and risk stratification protocols.
Optain Health · Australia
AI-powered platform that analyzes retinal images to identify early signs of eye diseases and assess cardiovascular disease risk. The system provides standardized risk assessment reporting to support clinical decision-making and reduce missed diagnoses.
ATCOR MEDICAL PTY LTD · China
Cardiovascular function detection system designed for comprehensive vascular and cardiac assessment. Enables non-invasive evaluation of arterial stiffness and central hemodynamics.
CLD · China
Advanced diagnostic system providing non-invasive assessment of cardiac structure and function. Used in cardiovascular health screening and clinical evaluation protocols across healthcare facilities.
27 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products